Tissue Factor

MacFarlane R. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier. Nature 1964; 202: 498–499.

Davie E. Ratnoff O. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310–12.

Osterud B. Rapaport S. I. Activation of Factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260–64.

Ragni M. Lewis J. Spero J. Hasiba U. Factor VII deficiency. Am J Hematol 1981; 10: 79–88.

Tuddenham E. Cooper D. The molecular genetics of haemostasis and its inherited disorders. Oxford: Oxford Medical Publications, 1994.

Mannhalter C. Fischer M. Hopmeier P. Deutsch E. Factor XII activity and antigen concentration in patients suffering from recurrent thrombosis. Fibrinolysis 1987; 1: 259–63.

Goodnough L. Saito H. Ratnoff O. Thrombosis or myocardial infarction in congenital clotting factor abnormalities. Medicine 1983; 62: 248–55.

Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol 1992; 29: 170–76.

Broze G J Girard T J Novotny W. F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539–46.

Carson S D Brozna J. P. The role of tissue factor in the production of thrombin. Blood Coag Fibrinol 1993; 4: 281–92.

Broze G. J. Binding of human factor VII and FVIIa to monocytes. J Clin Invest 1982; 70: 526–35.

Broze G. J. The tissue factor pathway of coagulation: Factor VII, tissue factor and tissue factor pathway inhibitor. In: Bloom A. Forbes C. Thomas D. Tuddenham E G D eds. Haemostasis and thrombosis, third edition, Volume 1. Edinburgh: Churchill Livingstone, 1994: 349–77.

Naito K. Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and FXIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353–58.

Broze G J Warren L A Novotny W F Higuchi D. Girard J. Miletich J. The lipoprotein associated coagulation inhibitor that inhibits the factor VII–tissue factor complex also inhibits factor Xa. Blood 1988; 71: 335–43.

Fisher K. Gorman C. Vehar G. . Cloning and expression of tissue factor cDNA. Throm Res 1987; 48: 89–99.

Scarpati E. Wen D. Broze G. Human tissue factor: Cdna sequence and chromosome localisation of the gene. Biochemistry 1987; 26: 5234–38.

Spicer E. Horton R. Bloem L. . Isolation of cDNA clones coding for human tissue factor. Primary structure of the protein and cDNA. Proc Natl Acad Sci USA 1987; 84: 5148–52.

Morrissey J. Fahkrai H. Edgington T. S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50: 129–35.

Boys C W G Miller A. Harlos K. Martin D. Tuddenham E D G O'Brien D. P. Crystallization and preliminary X-ray analysis of human tissue factor extracellular domain. J Mol Biol 1993; 234: 1263–65.

Bazan J. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934–38.

Harlos K. Martin D M A O'Brien D P . Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662–66.

De Vos A. Ultsch M. Kossiakoff A. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 1992; 255: 306–12.

Jones E. Davis S. Williams A. Harlos K. Stuart D. Crystal structure of 2.8Å resolution of a soluble form of the cell adhesion molecule. Nature 1992; 360: 232–39.

O'Brien D. Anderson J. Martin D. Byfield P. Tuddenham E. Structural requirements for the interaction between tissue factor and factor VII: Characterization of chymotrypsin-derived tissue factor polypeptides. Biochem J 1993; 292: 7–12.

Roy S. Hass P E Bourell J. Henzel W. Vehar G. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem 1991; 266: 22063–66.

Ruf W. Miles D. Rehemtulla A. Edgington T. S. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor–factor VIIa protease complex. J Biol Chem 1992; 267: 6375–81.

Ruf W. Schullek J. Stone M. Edgington T. Mutational mapping of functional residues in Tissue Factor: Identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 1994; 33: 1565–72.

Wang J. Yan Y. Garrett T. . Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 1990; 348: 411–18.

Paborsky L. Tate K. Harris R. . Purification of recombinant human tissue factor. Biochemistry 1989; 28: 8072–77.

O'Hara P. Grant F. Haldeman B. . Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987; 84: 5158–62.

Tulinsky A. The structures of the domains of blood proteins. Thomb Haemost 1991; 66: 16–31.

Wildgoose P. Jorgensen T. Komiyama Y. Nakagaki T. Pedersen A. Kisiel W. The role of phospholipids in the interaction of factor VII with tissue factor. Thomb Haemost 1992; 67: 679–85.

Martin D. O'Brien D P Tuddenham E D G Byfield P. Synthesis and characterization of wild-type and variant γ-carboxy glutamic acid-containing domains of FVII. Biochemistry 1993; 32: 13949–55.

Park C H Chang H. Tulinsky A. Three dimensional structure of the kringle sequence: Structure of prothrombin fragment 1. Biochemistry 1986; 25: 3977–82.

Stenflo J. Ohlin A. Persson E. Valcare C. Astermark J. Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationships. Ann N Y Acad Sci 1991; 614: 11–29.

Toomey J R Smith K J Stafford D. W. Localization of the human tissue factor recognition determinant of human FVIIa. J Biol Chem 1991; 266: 19198–202.

Clarke B J Ofusu F. Srihara S. Bona R D Rickles F. Blajchman M. A. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Lett 1992; 298: 206–10.

Takamiya O. Kemball-Cook G. Martin D. . Detection of missense mutations by single strand conformational polymorphism (SSCP) analysis in five dysfunctional variants of coagulation factor VII. Hum Mol Genet 1993; 2: 19198–202.

Sridhara S. Clarke B J Ofusu F. High K. Blajchman M. The direct binding of human factor VII in plasma to recombinant tissue factor. Blood Coag Fibrinol 1993; 4: 505–506.

O'Brien D P Kemball-Cook G. Hutchinson A M . Surface plasmon resonance studies of the interaction between TF and FVII. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII–R79Q). Biochemistry 1995 (in press).

Kumar A. Blumenthal D. Fair D. S. Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex. J Biol Chem 1991; 266: 915–21.

Wildgoose P. Kazim A. Kisiel W. The importance of residues 195–206 of human blood clotting factor VII in the interaction of FVII with tissue factor. Proc Natl Acad Sci USA 1990; 87: 7290–94.

O'Brien D P Gale K M Anderson J. . Purification and characterization of FVII 304Gln: A variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991; 78: 132–40.

Neuenschwander P. Branam D. Morrissey J. Importance of substrate composition pH and other variables on tissue factor enhancement of FVIIa activity. Thromb Haemost 1993; 70: 970–77.

Nemerson Y. Gentry R. An ordered addition, essential activation model of the tissue factor pathway of coagulation: Evidence for a conformational cage. Biochemistry 1986; 25: 4020–33.

Bach R. Nemerson Y. Konigsberg W. Purification and characterization of bovine tissue factor. J Biol Chem 1981; 256: 8324–31.

Rao L. Rapaport S. Hoang A. Binding of factor VIIa to tissue factor permits rapid anti-thrombin III-heparin inhibition of FVIIa. Blood 1993; 81: 2600.

Lawson J. Butenas S. Ribarik N. Mann K. Complex dependent inhibition of FVIIa by ATIII and heparin. J Biol Chem 1993; 268: 767.

Nakagaki T. Foster D C Berkner K L Kisiel W. Initiation of the extrinsic pathway of coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation Factor VII. Biochemistry 1991; 30: 10819–24.

Pedersen A. Lund-Hansen T. Bisgaard-Frantzen H. Olsen F. Petersen L. C. Autoactivation of human recombinant coagulation factor FVII. Biochemistry 1989; 28: 9331–36.

Morrissey J. Macik B. Neuenschwander P. Comp P. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734–44.

Drake T A Morrissey J H Edgington T. S. Selective expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087–97.

Rivers R. Hathaway W. Weston W. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311–15.

Prydz H. Lyberg T. Deteix P. Allison A. In vitro stimulation of tissue thromboplastin (Factor III) activity in human monocytes by immune complexes and lectins. Thromb Res 1979; 15: 465–74.

Nawroth P. Handley D. Esmon C T Stern D. Interleukin 1 induces endothelial cell procoagulant activity while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460–64.

Niemetz J. The role of protein synthesis on the generation of tissue factor activity in leukocytes. Proc Soc Exp Biol Med 1972; 139: 1276–79.

Levy G. Edgington T. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med 1980; 151: 1232–44.

Wilcox J. Smith K. Schwartz S. Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839–43.

Warr T. Rao L. Rapaport S. Disseminated intravascular dissemination in rabbits induced by administration of endotoxin or tissue factor. Blood 1990; 75: 1481–89.

Taylor F. Chang A. Morrissey J. Edgington T. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127–34.

Levy G. Schwartz B. Edgington T. The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lypopolysaccharide. J Immunol 1981; 127: 357–63.

Colucci M. Balconi G. Lorenzet R. . Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893–96.

Nawroth P. Stern D. Modulation of endothelial cell hemostatic properties by tumour necrosis factor. J Exp Med 1986; 163: 740–45.

Kirchhofer D. Sakariassen K. Clozel M. . Relationship between tissue factor expression and deposition of fibrin, platelets and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 1993; 81: 2050–58.

Pawashe A. Golino P. Ambrosio G. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56–63.

Gouault-Heilmann M. Chardon E. Sultan C. Josso F. The procoagulant factor of leukaemic promyelocytes. Demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1979; 30: 151–58.

Edgington T. S. Activation of the coagulation system in association with neoplasia. J Lab Clin Med 1980; 96: 1–4.

Edwards R. Rickles F. Mortiz T. Abnormalities of blood coagulation tests in patients with cancer. Am J Pathol 1987; 88: 596–602.

Thompson W. Smith E. Atherosclerosis and the coagulation system. J Pathol 1989; 159: 97–106.

Fernandez-Ortiz A. Badimon J. Falk E. . Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1562–69.

Tipping P. Malliaros J. Holdsworth S. Procoagulant activity expression by macrophages from atheromatous plaques. Atherosclerosis 1989; 79: 237–43.

Serneri Neri G. Abatte R. Gensini G. Gori A. Attanasio M. Martini F. Monocyte activation and increased procoagulant activity in unstable angina. Lancet 1990; 336: 1444–45.

Serneri Neri G. Abatte R. Gori A. . Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790–97.

Marmur J. Rossikhina M. Guha R. . Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253–59.

Taubman M. Marmur J. Rosenfield C. Guha A. Nichtberger S. Nemerson Y. Agonist mediated tissue factor expression in cultured vascular smooth muscle cells. J Clin Invest 1993; 91: 547–52.

Taubman M. Tissue factor regulation in vascular smooth muscle. A summary of studies performed in vivo and in vitro. Am J Cardiol 1993; 72: 55–60.

Thomas D. Pathogenesis of venous thrombosis. In: Bloom A. Forbes C. Thomas D. Tuddenham E G D eds. Haemostasis and thrombosis, third edition, Volume 2. Edinburgh: Churchill Livingstone, 1994.

Gitel S. Stephenson R. Wessler S. The in vivo and in vitro correlation of clotting protease activity. The effect of heparin. Proc Natl Acad Sci USA 1977; 74: 3028–34.

Clozel M. Kuhn H. Baumgartner H. Procoagulant activity of endotoxin-treated human endothelial cells exposed to native flowing blood. Blood 1989; 73: 729.

Kirchhofer D. Tschopp T. Hadvary P. Baumgartner H. Endothelial cells stimulated with tumour necrosis factor alpha express varying amounts of tissue factor resulting in inhomogeneous fibrin deposition in a native blood flow system. J Clin Invest 1994; 93: 2073–83.

Hoffman C. Shah A. Sodums M. Hultin M. FVII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475–81.

DeSouza J. Azevedo J. Soria C. . FVII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165–73.

Meade T. Mellos S. Brozovic M. . Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park heart study. Lancet 1986; 2: 533–37.

Miller G. Walter S. Stirling Y. Thomson S. Esnouf M. Meade T. Assay of FVII activity by two techniques. Evidence for increased conversion of FVII to FVIIa in hyperlipidaemia. Br J Haematol 1985; 59: 249–58.

Mitropoulos K. Esnouf M. Meade T. Increased FVII activity in the rabbit following diet induced hypercholesterolaemia. Atherosclerosis 1987; 63: 43–52.

Suzuki T. Yamauchi K. Matsushita T. . Elevation of FVII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731–36.

Collins P. Roderick A. O'Brien D. . Factor VIIa and other haemostatic variables following bone marrow transplantation. Thromb Haemost 1994; 72: 28–32.